Angled-tip vs. Straight-tip Guidewire in Biliary Cannulation

Sponsor
Lahey Clinic (Other)
Overall Status
Recruiting
CT.gov ID
NCT05600270
Collaborator
(none)
250
1
2
12.1
20.7

Study Details

Study Description

Brief Summary

Our aim is to compare outcomes between an angled-tip guidewire and a straight-tip guidewire in cannulation of the common bile duct during ERCP. This is a randomized, controlled, single-blinded study. Our primary outcome is success of cannulation and secondary outcomes are incidence of post-ERCP pancreatitis, procedure duration, and rate of complication between the angled wire and straight wire.

Condition or Disease Intervention/Treatment Phase
  • Device: Angled guidewire
  • Device: Straight guidewire
N/A

Detailed Description

Wire-guided cannulation of the common bile duct is a standard technique utilized during Endoscopic Retrograde Cholangio-Pancreatography (ERCP) to ensure safe and effective access to the common bile duct via the ampulla of Vater. Due to the anatomy of the ampulla, and the orientation of the biliary orifice, a guidewire with an angled tip may allow easier and safer access to the common bile duct without inadvertent manipulation of the pancreatic duct. We aim to assess the technical and clinical outcomes between an angled-tip guidewire (GW) compared to a straight-tip guidewire in wire-guided cannulation of the common bile duct. We hypothesize that an angled-tip GW is associated with increased rate of successful cannulation, decreased procedure time and decreased rate of post-ERCP pancreatitis in wire-guided biliary cannulation during ERCP.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
250 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized, Controlled, Single-Blinded TrialRandomized, Controlled, Single-Blinded Trial
Masking:
Single (Participant)
Masking Description:
Single-blinded study with masking of participant
Primary Purpose:
Treatment
Official Title:
Comparison Between an Angled-tip and Straight-tip Guidewire in Biliary Cannulation: a Prospective, Randomized Trial
Actual Study Start Date :
Oct 22, 2022
Anticipated Primary Completion Date :
Oct 25, 2023
Anticipated Study Completion Date :
Oct 25, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Angled wire

Angled guidewire intervention arm

Device: Angled guidewire
Cannulation of the common bile duct using an angled-tip guidewire during ERCP

Active Comparator: Straight wire

Straight guidewire intervention arm

Device: Straight guidewire
Cannulation of the common bile duct using an straigh-tip guidewire during ERCP

Outcome Measures

Primary Outcome Measures

  1. Cannulation [Day of Procedure]

    successful cannulation of common bile duct

Secondary Outcome Measures

  1. post ERCP pancreatitis [Procedure day and up to day 5 post procedure]

    Incidence of post ERCP pancreatitis

  2. Duration [Day of procedure]

    Total duration of procedure

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • patients undergoing ERCP for cholangiography, bile or tissue sampling from the gallbladder or bile duct, or for treatment of biliary diseases (removal of common bile duct stones, biliary stent placement)
Exclusion Criteria:
  • Patients who are less than 18 years old

Pregnant patients

Patients who have undergone previous bile duct cannulation or sphincterotomy

Patients who have undergone prior endoscopic balloon dilation or needle-knife fistulotomy

Patients who have undergone gastric surgery (Billroth gastrectomy II, Roux-en-Y gastric bypass)

Patients with acute pancreatitis

Patients who refuse endoscopic intervention

Patients with ampullary tumor, duodenal stenosis, or pre-operatively proven pancreaticobiliary malunion

Contacts and Locations

Locations

Site City State Country Postal Code
1 Lahey Hospital and Medical Center Burlington Massachusetts United States 01805

Sponsors and Collaborators

  • Lahey Clinic

Investigators

  • Principal Investigator: Ann Marie Joyce, MD, Lahey Hospital & Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ann Marie Joyce, Director of Advanced Endoscopy, Lahey Clinic
ClinicalTrials.gov Identifier:
NCT05600270
Other Study ID Numbers:
  • 20223146
First Posted:
Oct 31, 2022
Last Update Posted:
Oct 31, 2022
Last Verified:
Oct 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Keywords provided by Ann Marie Joyce, Director of Advanced Endoscopy, Lahey Clinic
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 31, 2022